Omics of Cancer |
Bhati, Aniruddha
(Division Medical Biotechnology, School of BioSciences and Technology, VIT)
Garg, H. (Division Medical Biotechnology, School of BioSciences and Technology, VIT) Gupta, A. (Division Medical Biotechnology, School of BioSciences and Technology, VIT) Chhabra, H. (Division Medical Biotechnology, School of BioSciences and Technology, VIT) Kumari, A. (Division Medical Biotechnology, School of BioSciences and Technology, VIT) Patel, T. (Division Medical Biotechnology, School of BioSciences and Technology, VIT) |
1 | Barddli A, Parsons DW. Silliman N, et al (2003). Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949. DOI |
2 | Bentley OR (2006). Whole-genome re-sequencing. Curr Opin Genel Dev, 16,545-52. DOI |
3 | Benvenuti S, Arena S, BardelliA (2005). Identification of cancer genes by mutational profiling of turnor genomes. FEBS Lea, 579, 1884-90. DOI |
4 | Bemstein BE, Meissner A, Lander ES (2007). The manunalian epigenome. Cell, 2, 669-81. |
5 | Bird A (2007). Perceptions of epigenetics. Nalure, 447,396-8. |
6 | Ding L, Getz G, Wheeler DA, et al (2008). Somatic mUlations affect key pathways in lung adenocarcinoma. Nature, 455,1069-75. DOI ScienceOn |
7 | Estecio MR, issa JP (2011 ). Dissecting DNA hypermethyiation in cancer. FEBS Letters, 585, 2078-86. DOI |
8 | Feber A (2010). Global profiling of methylation in the cancer genome. Cancer Genet Cytagenet, 203, 44-65. |
9 | Fiers W, Contreras R, Duerinck F (1976). Complete nucleotidesequence of bacteriophage MS2-RNA - primary and secondary structure of replicase gene. Nature , 260, 500-7. DOI |
10 | Hanash SM, Pitteri SJ, Faca VM (2008). Mining the piasma proteome for cancer biomarkers. Nature, 452, 571 -9. DOI ScienceOn |
11 | Holliday R (1990). Mechanisms for the control of gene activity druingdevelopment. BiolRevCambr PhilosSoc, 65,431-71. |
12 | Hoque MO, Kim MS, Ostrow KL, et al (2008). Genomewide promoter analysis uncovers portions of the cancer methylome. Cancer Res, 68, 2661-70. DOI |
13 | http://www.ncbi.nlm.nih.gov/genome. |
14 | Hudson TJ, Anderson W, Artez A, et al (2010). International Cancer Genome Consortium International network of cancer genome projects. Nature, 464,993-8. DOI |
15 | Jones S, Hruban RH, Kamiyama M, et al (2009). Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217. DOI |
16 | La Deana WH, Valerie R, Philip G, et al (2009). Massively parallel sequencing of the polyadenylated transcriptome of C. elegans. Genome Res, 19, 657-66. DOI |
17 | Li X, Shen S, Wu M, et at (2011 ). Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 36, 585-91. |
18 | Lander ES, Linton LM, Birren B, et al (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860-921. DOI ScienceOn |
19 | Lay JO, Borgmann S, Liyanage R Wilkins CL(2006). Problems with the "omics". Trends in Analytical Chemistry, 25, 11 . DOI |
20 | Laderberg J, McCray AT (2001). 'Ome Sweet 'Ontics -- A genealogical treasury of words. The Scientist, 15, 8. |
21 | Moore LE, Pfeiffer RM, Zhang Z, et al (2012). Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using pre-diagnostic senun samples from the prostate lung colon and ovary (PLCO) cancer screening trial. Cancer, 118, 91-100. DOI |
22 | Morel NM, Holland lM, van der Greef J, et al (2004). Primer on medical genomics part XIV: Introduction to systems biology-A new approach to understanding disease and treatment. Maya Clin Proc, 79, 651-8. DOI |
23 | MUlTay S, Linardou H (2004). Proteomics and Cancer. STEP KINIKHZ OKOOI, 3, 49-56. |
24 | Ng PC, Levy S, Huang J, et al (2008). Genetic variation in an individual human exome. PLoS Genetics, 4, 1000160. DOI |
25 | Olsvik O , Wahlberg J, Peuerson B, et al (1993).- Use of automated sequencing of polymerase chain reactiongenerated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol, 31,22-5. |
26 | Pettersson E, Lundeberg J, Ahmadian A (2009). Generations of sequencing technologies. Genomics, 93, 105- 11. DOI |
27 | Schuster SC (2008). Next-generation sequencing transforms today's biology. Nat Methods, 5, 16-8. DOI |
28 | Raphael BJ, Volik S, Collins C, Pevzner PA (2003). Reconstructing tumor genome architectures. Bioinformatics, 19, 162-71. |
29 | Sanger F, Air GM, Barrell BG, et al (1977). Nucleotide sequence of bacteriophage phi X174 DNA. Nature, 265, 687-95. DOI ScienceOn |
30 | Sarah BN, Entily HT, Peggy DR, et al (2009), Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272-76. DOI |
31 | Shah Sp, MorinRD, Khattra J, et al (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature, 461, 809-13. DOI |
32 | Sjoblom T, Jones S, Wood LD, et al (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314,268-74. DOI ScienceOn |
33 | Stadler ZK, Vijai J , Thorn P, el al (2010). Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am, 24, 973-96. DOI |
34 | Stephens PJ, McBride DJ, Lin ML, et al (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005-10. DOI ScienceOn |
35 | Taguchi A, Politi K, Pitteri, et al (2011 ). Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell, 20, 289-99. DOI |
36 | Tripathi AK, Koringa PG , Jakhesara SJ, et al (2012). A preliminary sketch of horn cancer transcriplome in Indian zebu cattle. Gene, 1, 124-31. |
37 | Varela I, Tarpey P, Rame K, et al (2011). Exome sequencing identifies frequentmutation of the SWUSNF complex gene PBRMI in renal carcinoma. Nature, 469, 539-42 DOI |
38 | Wei X, Walia V, LinJC, et al (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nature Genetics, 43, 442-6. DOI |
39 | Venter Cl, Adams DM, Myers WE, et at (2001). The sequence of the human genome. Science, 291, 1304-51. DOI ScienceOn |
40 | Volik S, Zhao S, Chin K, et al (2003), End-sequence profiling: Sequence-based analysis of aberrant genomes. Proc Natl Acad Sci, 100, 7696-701. DOI |
41 | Weir BA, Michele S. Woo MS, Getz G, et al (2007). Characterizing the cancer genome in Iung adenocarcinoma. Nature, 450, 893-8. DOI |
42 | Wilkins MR, Appel R, Jennifer EVE, et al (1994), Guidelines for next 10 years of proteins. Proteomics, 6, 4-8. |